Tonix製藥控股 TNXP 深 滬
等待開盤 05-23 09:30:00 美东时间
13.12
-0.880
-6.29%
華盛通- 最 高14.01
- 今 開14.00
- 成交量 39.58万股
- 最 低 12.84
- 昨 收 14.00
- 總市值 2.09亿
- 52周最高 69.97
- 市盈率 靜 --
- 換手率 2.48%
- 52周最低 11.6028
- 委 比 -72.41%
- 總股本 1594.08万
- 歷史最高 13440000000.00
- 量 比 1.44
- 振 幅 8.36%
- 歷史最低 11.6028
- 每 手 1
- 風險率 11.23%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Tonix Pharmaceuticals posts TNX-4800 Lyme disease prevention presentation
Tonix Pharmaceuticals posts TNX-4800 Lyme disease prevention presentation Tonix Pharmaceuticals published a medical research presentation outlining TNX-4800, a long-acting, bactericidal human anti-OspA monoclonal antibody being developed to prevent Lyme disease in the U.S. Program concept centers on
05-18 21:52
Tonix publishes TNX-1500 xenotransplantation workshop presentation
Tonix publishes TNX-1500 xenotransplantation workshop presentation Tonix published a medical research presentation outlining its TNX-1500 anti-CD40L monoclonal antibody program for prevention of kidney transplant rejection, including applications in clinical xenotransplantation. The deck positions T
05-18 21:51
Tonix Pharma advances TNX-4800 Lyme vaccine program
Tonix Pharma ( ($TNXP) ) has issued an announcement. On May 15, 2026, Tonix Pha...
05-15 21:48
Tonix Pharmaceuticals Q1 EPS $(2.93) Misses $(2.43) Estimate, Sales $6.878M Beat $6.100M Estimate
Tonix Pharmaceuticals (NASDAQ:TNXP) reported quarterly losses of $(2.93) per share which missed the analyst consensus estimate of $(2.43) by 20.58 percent. This is a 3.17 percent decrease over losses of $(2.84) per share
05-12 04:36
Why Tonix Pharmaceuticals Shares Are Rallying Wednesday
Tonix Pharmaceuticals Holding shares are trading higher Wednesday after announcing commercial payer coverage for fibromyalgia drug TONMYA.
05-06 20:56
Tonix rises on commercial payer coverage for pain therapy
Tonix Pharmaceuticals (TNXP) added ~6% in the premarket on Wednesday after announcing an agreement with a group purchasing organization to secure commercial payer coverage for Tonmya, its non-opioid p...
05-06 20:12
美股大行评级 | 潜在涨幅85%！SoFi获机构升目标价至49美元；华尔街大行看涨AMD至400美元
今日重点评级关注：Canaccord Genuity：维持Sagimet Biosciences"买入"评级，目标价从28美元升至49美元；HC Wainwright & Co.：维持Fate Therapeutics"买入"评级，目标价从5美元升至7美元
05-05 11:40
TD Cowen Initiates Coverage On Tonix Pharmaceuticals with Buy Rating, Announces Price Target of $22
TD Cowen analyst Stacy Ku initiates coverage on Tonix Pharmaceuticals (NASDAQ:TNXP) with a Buy rating and announces Price Target of $22.
05-05 01:52
财报速睇 | Tonix制药控股 2026财年Q1营收0.07亿美元，同比增长187.5%；归母净利润亏损0.41亿美元，同比亏损扩大142.9%
华盛资讯5月2日讯，Tonix制药控股公布2026财年Q1业绩，公司Q1营收0.07亿美元，同比增长187.5%，归母净利润亏损0.41亿美元，同比亏损扩大142.9%。
05-02 06:34
Tonix Pharma Announces Administrative Update to Regulatory Filing
Tonix Pharma ( ($TNXP) ) has issued an update. Tonix Pharma disclosed that cert...
05-02 06:12
